Back
The Descartes Systems Group Vs. Blueprint Medicines Industry Stock Comparison
Sell
48
DSGX
The Descartes Systems Group
Last Price:
$104.93
Seasonality Move:
0.67%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Sell
48
The Descartes Systems Group (DSGX)
is a Sell
Is The Descartes Systems Group a Buy, Sell or Hold?
-
The current The Descartes Systems Group [DSGX] share price is $104.19. The Score for DSGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
DSGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DSGX Stock Price Chart
What is The Descartes Systems Group's stock price today?
-
The The Descartes Systems Group share price today is $104.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGX is experiencing selling pressure, which indicates risk of future bearish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
DSGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 28.66 | Buy |
Relative Strength Index (14 RSI): | 51.93 | Buy |
Chaikin Money Flow: | -332745 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.91 - 103.93) | Buy |
Bollinger Bands (100): | (99.25 - 110.17) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.49 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.07 - 129.15) | Buy |
Bollinger Bands (100): | (85.79 - 122.45) | Buy |
DSGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.6 | Buy |
20-day SMA: | 102.71 | Buy |
50-day SMA: | 106.18 | Sell |
200-day SMA: | 108.75 | Sell |
8-day EMA: | 95.54 | Buy |
20-day EMA: | 65.53 | Buy |
50-day EMA: | 34.12 | Buy |
200-day EMA: | 9.84 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.38 | Buy |
20-day SMA: | 128.73 | Buy |
50-day SMA: | 119.37 | Buy |
200-day SMA: | 99.85 | Buy |
8-day EMA: | 129.26 | Buy |
20-day EMA: | 127.9 | Buy |
50-day EMA: | 120.09 | Buy |
200-day EMA: | 103.72 | Buy |
The Descartes Systems Group Earnings Growth & DSGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.03 per share, an increase this year of $0.62 per share, and an increase next year of $0.11 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
The Descartes Systems Group Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |